Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis
- DOI
- 10.1038/s41698-026-01371-8
- Published
- 2026-03-18
- Container
- npj Precision Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41698-026-01371-8,
title = {Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis},
author = {Yasuyoshi Sato and Naoki Fukuda and Koji Yamamura and Yusuke Ito and Kenya Kobayashi and Yuki Saito and Kousuke Watanabe and Hidenori Kage and Katsutoshi Oda and Shunji Takahashi},
year = {2026},
journal = {npj Precision Oncology},
doi = {10.1038/s41698-026-01371-8},
url = {https://doi.org/10.1038/s41698-026-01371-8}
}RIS
TY - JOUR TI - Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis AU - Yasuyoshi Sato AU - Naoki Fukuda AU - Koji Yamamura AU - Yusuke Ito AU - Kenya Kobayashi AU - Yuki Saito AU - Kousuke Watanabe AU - Hidenori Kage AU - Katsutoshi Oda AU - Shunji Takahashi PY - 2026 JO - npj Precision Oncology DO - 10.1038/s41698-026-01371-8 UR - https://doi.org/10.1038/s41698-026-01371-8 ER -
APA
Sato, Y., Fukuda, N., Yamamura, K., Ito, Y., Kobayashi, K., Saito, Y., Watanabe, K., Kage, H., Oda, K., & Takahashi, S. (2026). Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysis. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01371-8
Source records
- crossref · retrieved 2026-09-26T15:57:04.423Z